CDK7 expression is correlated with poor prognosis and overall survival in triple-negative breast cancer, gastric cancer, ovarian cancer, oral squamous cell carcinoma, hepatocellular carcinoma, and glioblastoma (112–118). This evidence concerns the gene CDK7 and triple-negative breast carcinoma.